Gianni; Luca

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gianni; Luca.The latest application filed is for "identification of patients in need of pd-l1 inhibitor cotherapy".

Company Profile

1.6.15

Gianni; Luca - Milano IT
Gianni; Luca - Milan N/A IT
Gianni; Luca - Milano Mi IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Identification Of Patients In Need Of Pd-l1 Inhibitor Cotherapy App 20220282337 - Belousov; Anton ; et al.	2022-09-08
Identification Of Patients In Need Of Pd-l1 Inhibitor Cotherapy App 20220170115 - Belousov; Anton ; et al.	2022-06-02
Identification Of Patients In Need Of Pd-l1 Inhibitor Cotherapy App 20220090212 - BELOUSOV; Anton ; et al.	2022-03-24
Identification Of Patients In Need Of Pd-l1 Inhibitor Cotherapy App 20200199690 - BELOUSOV; Anton ; et al.	2020-06-25
Identification Of Patients In Need Of Pd-l-1 Inhibitor Cotherapy App 20180274038 - Belousov; Anton ; et al.	2018-09-27
Gene expression markers for predicting response to chemotherapy Grant 9,605,318 - Baker , et al. March 28, 2	2017-03-28
Identification Of Patients In Need Of Pd-l1 Inhibitor Cotherapy App 20160333414 - BELOUSOV; Anton ; et al.	2016-11-17
Gene Expression Markers for Predicting Response to Chemotherapy App 20110129833 - Baker; Joffre B. ; et al.	2011-06-02
Gene expression markers for predicting response to chemotherapy Grant 7,871,769 - Baker , et al. January 18, 2	2011-01-18
Use of 7-t-butoxyiminomethylcamptothecin for the preparation of a medicament for the treatment of uterine neoplasms Grant 7,700,613 - Carminati , et al. April 20, 2	2010-04-20
Capecitabine Combination Therapy App 20090311249 - Gianni; Luca ; et al.	2009-12-17
Use Of 7-T-Butoxyiminomethylcamptothecin For The Preparation Of A Medicament For The Treatment Of Uterine Neoplasms App 20080020030 - Carminati; Paolo ; et al.	2008-01-24
Combined use of ecteinascidin-743 and platinum antineoplastic compounds App 20070128201 - D'Incalci; Maurizio ; et al.	2007-06-07
Combination therapy comprising the use of et-743 and doxorubicin for treating cancer App 20070082856 - Gianni; Luca ; et al.	2007-04-12
Gene expression markers for predicting response to chemotherapy App 20050260646 - Baker, Joffre B. ; et al.	2005-11-24
Method for reducing toxicity of combined chemotherapies Grant 6,927,211 - Minotti , et al. August 9, 2	2005-08-09
Method for reducing toxicity of combined chemotherapies Grant 6,906,040 - Minotti , et al. June 14, 2	2005-06-14
Method for reducing toxicity of combined chemotherapies App 20040077561 - Minotti, Giorgio ; et al.	2004-04-22
Method for reducing toxicity of combined chemotherapies App 20020049169 - Minotti, Giorgio ; et al.	2002-04-25
Method for reducing toxicity of combined chemotherapies App 20020049170 - Minotti, Giorgio ; et al.	2002-04-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.